News | Enterprise Imaging | September 25, 2018

Laurel Bridge Enables Healthcare Providers to Manage Image Archive Migrations and Consolidations

Improved Exodus Migration and Consolidation Controller provides enterprises the flexibility and control to migrate legacy and other medical imaging data

Laurel Bridge Enables Healthcare Providers to Manage Image Archive Migrations and Consolidations

September 25, 2018 — Laurel Bridge Software announced improvements to their Exodus Migration and Consolidation Controller that enhance the ability of healthcare providers to internally manage their own medical image archive migration and consolidation requirements.

The latest updates to Exodus help ensure that clinician access to historical medical imaging information can be an integral part of any healthcare organization’s enterprise imaging strategy that may be implemented using either of the following approaches:

  • Self-managed through internal expertise; or
  • Service-provider-managed through Laurel Bridge.

The following new capabilities make it easy for organizations to bring the necessary migration and consolidation expertise in-house:

  • An easily configured graphical user interface;
  • Improved migration status monitoring tools;
  • Faster migrations by leveraging load balancing capabilities;
  • Improved performance, in particular for study-based queries; and
  • Support for a Source-of-Truth migration approach.

In addition, the Exodus - Migration and Consolidation Controller can work in concert with other Laurel Bridge software solutions, such as the Compass ‑ Routing Workflow Manager and Navigator ‑ Imaging Retrieval Workflow Manager to manage complex migrations and data orchestration requirements. This capability can be especially helpful for organizations that have recently merged or have been acquired.

Jeff Kelly, CIO at Nuvodia, a healthcare IT management services provider, stated, “Using Exodus to bring our migration expertise in-house has enabled us to improve customer delivery and reduce costs. We are able to put our customers at ease because of the flexibility and robustness of the Laurel Bridge solutions.”

For more information: www.laurelbridge.com

Related Content

Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
International medical imaging IT and cybersecurity company Sectra will install its solution for digital pathology at Institut Curie, one of the most recognized and prestigious cancer centers in France.
News | Enterprise Imaging | May 24, 2021
May 24, 2021 — International medical imaging IT and cybersecurity company ...
The Healthcare Information and Management Systems Society, Inc. (HIMSS) 2021 Conference, scheduled for August 9-13 in Las Vegas, will be one of the first to take a step back to normalcy

Getty Images

News | HIMSS | May 17, 2021
May 17, 2021 — It looks like in-person conferences are making a comeback.
Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Feature | Imaging Technology News - ITN | May 17, 2021 | By Melinda Taschetta-Millane
Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address

Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address inherent biases in healthcare algorithms and their deployment. Image courtesy of Regenstrief Institute

News | Artificial Intelligence | May 14, 2021
May 14, 2021 — Artificial intelligence